why choose us

First received: December 06, 2023

Clinical Trial: A Randomised Trial Comparing the Ovarian Response of a Starting Dose of Either 10 ?g or 15 ?g Follitropin Delta (FE 999049) to a Starting Dose of Either 150 IU or 225 IU Follitropin Alfa (GONAL-F) in Conventional Regimens in China

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Infertility, Female

Study Type: INTERVENTIONAL


Official Title: A Randomised, Controlled, Assessor-blind, Parallel Groups, Multicentre Trial Comparing the Ovarian Response of a Starting Dose of Either 10 ?g or 15 ?g Follitropin Delta (FE 999049) to a Starting Dose

Brief Summary: This is a phase 3b clinical trial with follitropin delta (FE 999049) and Gonal-F.The trial is a randomised, controlled, assessor-blind, parallel groups, multicentre trial comparing the ovarian response of a starting dose of either 10mg or 15 mg follitropin delta to a starting dose of either 150 IU or 225 IU Gonal-F in a long GnRH agonist protocol in women undergoing an assisted reproductive technology programme in China.

Read more